Penetration Testing in MedTech: Protecting Patient Data, AI Platforms, and Regulatory Compliance

TL;DR: Key Takeaways

• Healthcare is the most targeted and most expensive sector for data breaches, averaging $7.42 million per incident, more than any other industry.
• MedTech platforms face a distinct threat model: sensitive patient data, complex regulatory obligations, AI-driven clinical workflows, and integration with medical device infrastructure all create attack surfaces that generic security tools are not built to assess.
• Penetration testing in healthcare is not a compliance checkbox. It is the mechanism by which organisations validate that their security controls actually hold under adversarial pressure, before regulators or attackers find out they do not.
• Cyrex has conducted structured security assessments across live MedTech platforms, including AI-driven medical assessment tools and dialysis software integrated with medical device infrastructure.
• Recurring, structured engagements, not one-off assessments, are the standard that patient safety and regulatory frameworks demand.

The Stakes in MedTech Are Unlike Any Other Sector

Healthcare has held the top spot for data breach costs across every industry for fourteen consecutive years. The average breach now costs $7.42 million per incident. Medical records sell on dark markets at ten times the value of financial data, precisely because they never expire and contain identity information that enables fraud, medical identity theft, and targeted extortion.

But the financial impact is only part of the picture. In 2025, the healthcare sector was ranked the top target for cyberthreats by the FBI. Nearly half of all healthcare organisations reported experiencing at least one security incident in the past year. More significantly, 28% of organisations reported higher patient mortality rates as a direct consequence of cyberattacks in 2024. In MedTech, a breach is not simply a data event. It is a patient safety event.

For MedTech companies building AI-driven platforms, dialysis software, remote monitoring tools, or connected diagnostic systems, the attack surface extends beyond the application layer. It includes the communication infrastructure between client and server, the integrity of clinical data in transit, authentication systems controlling access to sensitive records, and the compliance posture that regulators will scrutinise when something goes wrong.

The MedTech Threat Model: What Makes It Different

Patient Data Is the Primary Target

Protected health information is the most valuable data class in the cybercrime economy. Unlike financial credentials, which can be cancelled, a patient's medical history, medication records, and identifying information cannot be changed. Attackers know this. So do regulators.

Under GDPR, a breach involving patient data carries penalties of up to 20 million euros or 4% of global annual turnover. Under HIPAA, OCR penalty enforcement increased by 340% between 2024 and 2025. NIS2, now transposed into national law across EU member states, imposes mandatory breach reporting within 24 hours for entities operating in or supplying healthcare infrastructure. The regulatory exposure from a breach is not theoretical. It is calculated, enforced, and publicly disclosed.

AI-Driven Platforms Introduce New Vulnerability Classes

As MedTech companies integrate artificial intelligence into clinical workflows, assessment tools, and diagnostic pipelines, they introduce vulnerability classes that traditional penetration testing frameworks were not designed to assess. These include model input manipulation, where adversarial inputs can produce clinically dangerous outputs; business logic flaws in AI decision pathways; and client-authoritative logic, where critical clinical decisions are processed client-side rather than validated server-side.

An AI platform that supports medical assessment or patient-doctor interaction is not simply a web application. It is a clinical tool, and its security controls need to be validated accordingly.

Medical Device Integration Expands the Attack Surface

MedTech platforms that communicate with medical device infrastructure via server integration introduce a communication layer that standard web application security tools cannot meaningfully inspect. Custom protocols, real-time data synchronisation, and proprietary networking stacks create exposure that only purpose-built testing methodologies can assess. If an attacker can manipulate data in transit between a medical device and its backend systems, the integrity of clinical data and patient safety are both at risk.

How Cyrex Approaches MedTech Security Testing

Pair Hacking: Testing the Way Attackers Actually Operate

Every Cyrex engagement is conducted under Pair Hacking: one senior offensive engineer paired with one proprietary AI agent on every assessment. The AI handles the grind at machine speed, including enumeration, protocol fuzzing, and edge-case detection. The human Architect handles the depth, validating exploit chains, challenging assumptions, and uncovering business-logic flaws that generic scanners and fully autonomous platforms routinely miss. The result is broader coverage, faster signal discovery, and deeper human-verified testing aligned to how real attackers pressure bespoke systems.

In MedTech environments specifically, this coordination matters across three dimensions: application security, where authentication logic and data handling need to be tested end to end; communication layer security, where data in transit between clients, servers, and device infrastructure must be validated; and business logic, where clinical workflows can contain flaws that only emerge under adversarial simulation rather than automated scanning.

Black Box, Grey Box, and White Box Testing

Cyrex delivers black box, grey box, and white box penetration testing based on the client’s requirements and the realities of the platform being assessed. From a security coverage and testing quality standpoint, white box is the recommended approach. Full visibility into architecture, source code, APIs, and infrastructure allows our team to assess internal logic, trust boundaries, and control implementation with far greater depth than an external-only view.

That said, we adapt the engagement model to the client’s constraints, maturity, and objectives. Black box testing simulates an external attacker with no prior knowledge. Grey box testing provides partial architectural visibility and reflects an attacker operating with reconnaissance or limited internal access. White box testing provides the strongest coverage and typically delivers the best return on the engagement because more time is spent validating meaningful attack paths instead of reconstructing context.

For MedTech platforms operating under ISO 27001 or preparing for audit, grey box and especially white box engagements also produce clearer technical evidence, stronger traceability, and more reproducible findings for internal security teams, compliance stakeholders, and regulators.

Cyrex in MedTech: Case Studies

Bingli: Securing an AI-Driven Medical Assessment Platform

Bingli operates in the healthcare technology space, using artificial intelligence to support medical assessment and patient-doctor interactions. The platform processes sensitive medical data, making confidentiality, integrity, and availability all critical.

Cyrex conducted a full penetration testing engagement across the Bingli platform, beginning with passive reconnaissance to map application architecture, technology stack, functional workflows, and exposure points. Active testing followed, with manual simulation of real-world attack scenarios targeting authentication and authorisation logic, input handling and data validation, and resilience against common web application attack vectors.

The engagement produced a structured report with all identified vulnerabilities, risk severity assessments, exploitation scenarios, and prioritised remediation guidance tailored to Bingli's operational environment. The outcome was a strengthened security posture, clear remediation guidance aligned with healthcare compliance requirements, and reinforced protection of patient and provider data.

Bingli noted that Cyrex provided clear and actionable recommendations that significantly contributed to their overall security strategy.

NIPRO Digital / NephroFlow: Recurring Testing for a Medical Device-Integrated Platform

NephroFlow is a process-driven dialysis software platform used by healthcare providers and patients for care planning and workflow management. The platform handles sensitive medical information and integrates with medical device infrastructure via server communication, introducing a communication layer that required specialist assessment.

Cyrex has conducted recurring white and grey box penetration testing engagements across both the web and mobile versions of NephroFlow, supporting NIPRO Digital's ISO 27001 certification programme.

Testing covered patient data privacy controls, role-based access controls and permission boundaries, authentication and authorisation workflows, denial-of-service resilience, business logic integrity, and intellectual property protection mechanisms. Particular attention was given to secure communication between the application and backend services, given the system's integration with medical device infrastructure.

Cyrex identified multiple high-priority vulnerabilities during testing, which were addressed promptly by the development team. The engagement structure, including regression testing after patching, ensures that remediation is validated rather than assumed. Annual testing provides NIPRO Digital with ongoing assurance that system resilience is maintained as the platform evolves.

Regulatory Compliance: What MedTech Organisations Need to Demonstrate

ISO 27001

ISO 27001 certification requires documented evidence of an ongoing information security management programme, including regular security assessments and structured risk management. Penetration testing is a core mechanism for generating that evidence. Cyrex's structured reporting, with CVSS-aligned severity scoring, reproducible findings, and remediation guidance, is designed to support audit processes directly.

NIS2

NIS2 applies to organisations operating in or supplying healthcare infrastructure across EU member states. It requires demonstrable risk management practices, supply chain security controls, and rapid incident reporting. A structured penetration testing programme is evidence of proactive risk management, which NIS2 enforcement bodies will expect to see.

GDPR

GDPR requires appropriate technical and organisational measures to protect personal data. In healthcare, where the data being processed is special category data under Article 9, the bar is higher. Documented security testing, with findings and remediation evidence, demonstrates that the organisation takes its obligations seriously and has taken concrete steps to validate its controls.

The Case for Recurring Engagement

A single penetration test validates your security posture at a point in time. MedTech platforms do not remain static. Features are added, integrations change, infrastructure evolves. Each change potentially introduces new vulnerabilities.

The NIPRO Digital engagement model, with annual recurring testing and regression validation after patching, reflects the standard that patient safety and regulatory frameworks actually require. It is not a one-off exercise. It is an ongoing programme of assurance that keeps pace with the platform.

For MedTech organisations preparing for ISO 27001 audits, regulatory inspections, or funding rounds where due diligence will include security assessment, a documented history of recurring, structured penetration testing is one of the strongest signals of a mature security programme.

Conclusion

MedTech security is not a technical problem with a technical solution. It is a patient safety obligation, a regulatory requirement, and a commercial imperative operating simultaneously. The organisations that treat penetration testing as a recurring discipline rather than a pre-launch formality are the ones that catch vulnerabilities before regulators, attackers, or patients do.

Cyrex brings structured, expert-led security testing to MedTech environments that demand more than automated scanning: AI-driven platforms, medical device-integrated systems, and compliance-critical infrastructure where the cost of getting it wrong is measured in patient outcomes, not just breach notifications.

Frequently Asked Questions

What is penetration testing in a MedTech context? Penetration testing in MedTech is the authorised simulation of real-world cyberattacks against healthcare technology platforms, including web and mobile applications, APIs, authentication systems, and communication infrastructure connecting to medical devices. The goal is to identify exploitable vulnerabilities before attackers or regulators do, with findings documented in a format that supports both remediation and compliance evidence.

Why is healthcare such a high-value target for cyberattacks? Medical records contain a combination of personal, financial, and clinical information that cannot be cancelled or changed, making them the most valuable data class in the cybercrime economy. They trade at around ten times the value of financial credentials on dark markets. Combined with the operational disruption that attacks cause to clinical workflows, healthcare organisations face both data theft and operational extortion as simultaneous threats.

How does penetration testing support ISO 27001 and NIS2 compliance? ISO 27001 requires ongoing security assessment as part of a documented information security management programme. NIS2 requires demonstrable risk management practices for organisations supplying healthcare infrastructure. Penetration testing provides the structured, documented evidence that both frameworks require: identified vulnerabilities, severity assessments, and remediation validation. Cyrex's reporting is designed to align directly with these compliance requirements.

What makes AI-driven MedTech platforms particularly challenging to secure? AI platforms introduce vulnerability classes beyond standard web application security, including adversarial input manipulation, business logic flaws in clinical decision pathways, and client-authoritative logic where critical processing occurs client-side without server-side validation. These require contextual, manual testing rather than automated scanning to identify, because the vulnerabilities emerge from the interaction of AI systems with user inputs and clinical workflows rather than from standard application code patterns.

What is the difference between black box, grey box, and white box penetration testing? Black box testing simulates an external attacker with no prior knowledge of the system. Grey box testing provides partial architectural information, simulating an attacker who has conducted reconnaissance. White box testing provides full visibility into architecture and source code, enabling the most thorough assessment of internal logic and control implementation. For MedTech platforms under compliance obligations, grey and white box engagements produce the most comprehensive and audit-ready findings.

How often should a MedTech platform undergo penetration testing? At minimum, annually, and additionally after any significant feature release, architectural change, or new integration. Regulatory frameworks including ISO 27001 and NIS2 expect ongoing rather than one-off assessment. Cyrex conducts recurring engagements with regression testing after patching, ensuring that remediation is validated and that new changes do not reintroduce previously resolved vulnerabilities.